Eradivir’s Breakthrough in Influenza Treatment: A New Hope for Viral Infections In the ever-evolving landscape of biotechnology, the quest for innovative treatments against viral infections remains a top priority. On July 9, 2024, Eradivir, a biotechnology company based in West Lafayette, Indiana, announced a significant milestone in this endeavor. The company is developing its lead […]